The biobanking equipment market is witnessing rapid growth, driven by the increasing demand for biological sample storage and research activities in fields such as genomics, personalized medicine, and regenerative therapies. Biobanks play a crucial role in medical research, providing vital resources for understanding genetic variations, disease mechanisms, and drug development. The growth of the biobanking equipment market is expected to continue as the need for efficient and reliable equipment for sample collection, processing, storage, and analysis rises.

Market Overview

Global market for biobanking equipment is expected to exhibit a high-single digit CAGR of 7.1% throughout the forecast period 2017 to 2022. Sales of biobanking equipment worldwide are estimated to surpass US$ 2,000 Mn in revenues by 2022-end. Several factors are contributing to this market expansion, such as the rise in genomic research, growing awareness about personalized medicine, and increasing investments in biobanks by research institutions, pharmaceutical companies, and government organizations. The growing need for biological samples for clinical trials and the development of innovative medical therapies further fuel the demand for biobanking equipment.

Biobanks serve as essential hubs for storing biological materials, including blood, tissues, DNA, RNA, and stem cells, which are critical for advancing medical research and therapeutic innovations. With the increasing complexity of biological data and the need for precision in sample preservation, the demand for advanced equipment for biobanks has surged.

Key Players

The biobanking equipment market is dominated by a few key players who provide a wide range of products and solutions. Some of the most notable companies in this market include Thermo Fisher Scientific Inc., Becton, Dickinson and Company (BD), QIAGEN N.V., Merck KGaA, and PHC Holdings Corporation. These companies manufacture state-of-the-art equipment such as freezers, cryogenic storage systems, sample processing devices, and automated systems that are essential for the management and preservation of biological samples.

Thermo Fisher Scientific, one of the leaders in the biobanking space, offers a broad array of solutions tailored to the specific needs of biobanks, such as cryogenic freezers, biological sample storage systems, and high-capacity refrigerated storage solutions. Similarly, QIAGEN provides advanced tools for nucleic acid extraction and purification, which are crucial for research purposes involving biological samples.

Future Opportunities

Emerging markets, particularly in Asia-Pacific, Latin America, and the Middle East, present significant opportunities for growth in the biobanking equipment market. As countries in these regions invest in healthcare infrastructure and biotechnology research, the demand for biobanks and their associated equipment is expected to rise. China, India, and South Korea are expected to be key contributors to this market expansion due to their growing focus on medical research, increasing healthcare investments, and the establishment of new biobanks.

Furthermore, the increasing adoption of precision medicine, where therapies are tailored based on individual genetic profiles, offers immense growth potential for the biobanking sector. Precision medicine requires large, well-maintained biobanks to collect and store genomic data, providing opportunities for equipment manufacturers to cater to the evolving needs of personalized medicine.

Additionally, advancements in cryogenic storage technologies and automated sample management systems present growth opportunities. The growing need for large-scale storage solutions, such as biorepositories and cryopreservation systems, will drive demand for sophisticated and efficient biobanking equipment.

Market Analysis

The biobanking equipment market is segmented based on equipment type, end-user, and region. The equipment segment, which includes freezers, liquid nitrogen tanks, cryogenic storage devices, sample storage systems, and automated sample processing equipment, dominates the market. Cryogenic freezers and automated systems are particularly in high demand as they ensure the safe and reliable storage of biological samples at ultra-low temperatures.

Biobanks, academic and research institutions, pharmaceutical and biotechnology companies, and diagnostic laboratories are the primary end-users of biobanking equipment. Biobanks, in particular, have seen a surge in the number of samples they handle due to the growing need for biological data in medical research, which has directly influenced the demand for more advanced and reliable storage and processing equipment.

North America currently holds the largest market share, with the U.S. and Canada being key contributors due to their well-established research infrastructure and the presence of major biobanks. The European market is also experiencing steady growth, driven by ongoing research projects and public-private partnerships aimed at advancing personalized medicine and genomics. The Asia-Pacific region, with its increasing healthcare investments and burgeoning biotechnology industry, is expected to exhibit the highest growth rate during the forecast period.

Recent Updates and Industry News

In recent years, there has been an increasing emphasis on the integration of automation and artificial intelligence (AI) in biobanking processes. Automation technologies help streamline sample collection, storage, and processing workflows, ensuring higher efficiency and reducing the risk of human error. AI-driven tools for data analysis and sample tracking are also gaining traction, enabling biobanks to manage vast amounts of biological data with greater precision and speed.

Sustainability is also emerging as a key focus within the biobanking industry. Many biobanks and equipment manufacturers are exploring eco-friendly solutions, such as energy-efficient storage systems and sustainable materials for equipment construction. Sustainable practices are gaining momentum as biobanks look to reduce their carbon footprint while maintaining the highest standards of sample preservation.

One of the most notable developments in the market is the increasing number of strategic partnerships and collaborations between biobanks, healthcare providers, and research organizations. For instance, major pharmaceutical companies are forming partnerships with biobanks to access rare and diverse biological samples for their research and drug development pipelines. Such collaborations are expected to drive further demand for biobanking equipment, as these partnerships often involve large-scale operations requiring advanced equipment and facilities.

Furthermore, public funding for biobanks is on the rise, particularly for initiatives related to genomics and personalized medicine. Governments and healthcare organizations are increasingly recognizing the importance of biobanks in advancing medical research and improving healthcare outcomes. This trend is likely to continue as more countries invest in healthcare and biotechnology infrastructure, further driving the demand for biobanking equipment.

Conclusion

The biobanking equipment market is poised for significant growth in the coming years, driven by advancements in medical research, personalized medicine, and technological innovations in sample storage and processing. Key players in the industry are actively innovating to meet the evolving needs of biobanks, which are becoming central to the development of new therapies and personalized healthcare solutions. As biobanks continue to expand globally, emerging regions such as Asia-Pacific will present new opportunities for growth. At the same time, advancements in automation, AI, and sustainability will shape the future of biobanking equipment, ensuring that biobanks can operate more efficiently and cost-effectively while maintaining high standards of sample preservation.

Read more –

As per a newly published research report by Fact.MR, the value of the global sodium amide market stands at US$ 723 million in 2023. Worldwide demand for sodium amide is forecasted to increase at a CAGR of 6.8% and reach a market value of US$ 1.4 billion by 2033.

The global market for harbor deepening solutions is valued at US$ 5.07 billion in 2023. Fact.MR reveals that worldwide revenue from harbor deepening is projected to rise at a CAGR of 3.5% and reach US$ 7.15 billion by 2033-end.

The global UV cured adhesives market is projected to advance at a CAGR of 5.5% from 2023 to 2033. As a result, worldwide demand for UV cured adhesives is expected to increase from a value of US$ 4.54 billion in 2023 to US$ 7.75 billion by 2033-end.

The global white cement market is valued at US$ 6.8 billion in 2023 and is projected to expand at a CAGR of 6.5% to reach US$ 13 billion by 2033-end, according to the latest market study by skilled analysts at Fact.MR.

Global soil compaction machine sales are estimated at US$ 5.4 billion and are forecasted to climb to US$ 10.6 billion by 2033-end. The global soil compaction machines market is projected to expand at a robust 6.8% CAGR over the next ten years.

The global crushing equipment market is valued at US$ 6.35 billion in 2023 and is projected to expand swiftly at a CAGR of 7.5% to reach US$ 13 billion by 2033-end, according to this latest market study by skilled analysts at Fact.MR.

The global automotive heater core market is valued at US$ 7.63 million in 2023 and is forecasted to expand at 3.5% CAGR over the next ten years. Global automotive heater core demand is projected to amass a valuation of US$ 10.76 billion by 2033-end.